Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-16-094564
Filing Date
2016-02-01
Accepted
2016-02-01 19:27:15
Documents
1
Period of Report
2016-01-29

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3182
  Complete submission text file 0001209191-16-094564.txt   4736
Mailing Address 5 SYLVAN WAY SUITE 300 PARSIPPANY NJ 07054
Business Address 5 SYLVAN WAY SUITE 300 PARSIPPANY NJ 07054 973-254-3560
Pacira Pharmaceuticals, Inc. (Issuer) CIK: 0001396814 (see all company filings)

EIN.: 510619477 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ESPERION THERAPEUTICS, INC. 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108
Business Address
Braunstein Scott (Reporting) CIK: 0001643875 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35060 | Film No.: 161378850